Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

BZ 2024 wrapped

8 Jan 2025
Antibodies | ADCs Automation Biomarkers Cell and gene therapies Chromatography Clinical Drug development Expert opinion General interest Interviews MS (LC–MS/MS, HRMS, IMS) News Oligonucleotides

2024 was quite the year for the bioanalytical community. For this year’s summary, we’ve put together a new and exclusive feature to say thank you for your continued support as our audience. Check out our mood board below, offering a visual summary of the year’s top bioanalysis content.

Simply zoom in and click on your favorite features to find out more!

BZ 2024 WRAPPED (2)

Top content

  • An author’s perspective: NAN technology with Cheryl Arrowsmith and Alexander Jackson
  • LC-DIA-MS/MS reveals aging- and pathology-specific molecular alterations in aging and Alzheimer’s disease
  • What to look out for at Analytica 2026

Related tags

2024 wrapped bioanalysis
Previous article Next article

Related articles

2 FEB 2022 DRUG DEVELOPMENT
Infographic: the future of bioanalysis for biologics development
18 NOV 2019 GENERAL INTEREST
What is bioanalysis? Bioanalysis Zone FAQs
24 FEB 2021 JOURNAL ARTICLES
The effectiveness of quality control samples in pharmaceutical bioanalysis
4 JAN 2018 NEWS
Bioanalysis volume 10, issue 1
6 MAY 2021 JOURNAL ARTICLES
Green bioanalytical sample preparation: fabric phase sorptive extraction
rat plasma
19 OCT 2023 JOURNAL ARTICLES
Development of an LC–MS/MS assay for quantification of intact INSL3 in rat plasma
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone